CAPSTAN Therapeutics
SETTING SAIL
Launch
- Media strategy and execution
- Media training
- Messaging development
- Science communications
- Social media/Digital marketing
- Strategic counsel and planning
A stacked deck of experts and technology
In 2022, Capstan Therapeutics chose Ten Bridge as its partner to launch the company and announce its Series A financing, highlighting its targeted in vivo cell engineering approach developed by world-renowned mRNA and cell therapy scientists and clinicians.
Charting a course with foundational messaging
With a deep roster of experts among its Scientific Founders and leadership team, as well as a blue-chip list of venture and corporate investors, Capstan was looking to clearly distinguish the company based on its expertise and the potential of its platform. Ten Bridge leveraged our media relations and scientific communications expertise to develop a distinctive message platform for the company and partnered with Capstan to pull those messages through to the corporate website, and through new social media channels.
